Community collaboration is 'critical' to drug strategy success, report says
The report said that a Health Research Board examination of drug treatment data found that while just 14% of the national population are from areas classified as disadvantaged that 42% of drug treatment cases, where opioids were the primary drug, came from disadvantaged areas. File picture
It is “critical” that communities which are most affected by drugs have a say in designing and implementing policies to address the problem, external experts have said.
The evaluation of the National Drugs Strategy (NDS) 2017-2025 said “funding and staffing constraints” were affecting community projects.
